We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Free speech mandates vacating off-label promotion conviction, says Second Circuit

07 December 2012

Litigation & Arbitration Alert

In a split decision raising significant questions for ongoing investigations, company practices, and future prosecutions, the United States Court of Appeals for the Second Circuit vacated a pharmaceutical sales representative’s conviction after concluding that his off-label promotion was constitutionally protected speech. The government had prosecuted the sales representative for conspiring to introduce a misbranded drug into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act (FDCA), and the government’s case to the jury focused on recorded conversations in which the sales representative engaged in speech about unapproved uses of an approved drug (also called off-label promotion). The appeals court held that the FDCA’s misbranding provisions do not criminalize the simple promotion of a drug for off-label use because such a construction of the statute would run afoul of the First Amendment.

Read: "Free speech mandates vacating off-label promotion conviction, says Second Circuit"

The team

Loading data